Thyrocare Technologies DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.72×	0.77×	0.62×	0.73×	0.74×
	0.84×	1.04×	1.09×	1.06×	1.07×
	25.6%	24.5%	19.7%	15.8%	15.4%
	1.15×	1.15×	1.03×	0.90×	0.85×
	1.31×	1.28×	1.27×	1.22×	1.18×
	23.3%	28.8%	17.2%	13.3%	12.3%
	28.8%	28.8%	17.1%	13.3%	12.2%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

THYROCARE₹515.50

Thyrocare Technologies Ltd.

· Pharma & Health

₹ CrorePeersLALPATHLAB METROPOLIS VIJAYA SUPRIYA VIYASH STAR SPARC YATHARTHMcap ₹8,205 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.74	0.73	0.62	0.77	0.72
Interest Burden (Pretax/EBIT) ×	1.07	1.06	1.09	1.04	0.84
EBIT Margin %	15.44	15.81	19.66	24.54	25.56
Asset Turnover ×	0.85	0.90	1.03	1.15	1.15
Financial Leverage (Assets/Equity) ×	1.18	1.22	1.27	1.28	1.31
ROE (5-step product, year-end total equity) %	12.28	13.35	17.22	28.80	23.25
ROE (owners' profit / average owners' equity) %	12.16	13.34	17.05	28.80	28.80

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.